NCT00004647View on ClinicalTrials.gov

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Mexiletine for Painful Diabetic Neuropathy

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 1993

Study Completion Date

February 28, 1999

Conditions
PainDiabetic NeuropathiesParesthesia
Interventions
DRUG

mexiletine

All Listed Sponsors
collaborator

University of Tennessee

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004647 - Phase III Randomized, Double-Blind, Placebo-Controlled Study of Mexiletine for Painful Diabetic Neuropathy | Biotech Hunter | Biotech Hunter